Medicare LVAD “Category B” Coverage Critical To Non-Pulsatile Device Firms
This article was originally published in The Gray Sheet
Executive Summary
CMS' imminent coverage decision on permanent implantation of left-ventricular assist devices may be limited to FDA-approved pulsatile designs
You may also be interested in...
Clash Of The LVADs: Continuous Flow Devices Moved To Lower-Paying DRG
MicroMed is seeking to regain sufficient inpatient reimbursement for its DeBakey left-ventricular assist device by the time Medicare coverage for LVADs as destination therapy becomes effective
Clash Of The LVADs: Continuous Flow Devices Moved To Lower-Paying DRG
MicroMed is seeking to regain sufficient inpatient reimbursement for its DeBakey left-ventricular assist device by the time Medicare coverage for LVADs as destination therapy becomes effective
Medicare Reform Bills Head To Conference; Competitive Bidding Fuels Debate
AdvaMed will work closely with Sens. Rick Santorum (R-Penn.) and Blanche Lincoln (D-Ark.) to ensure language easing criteria for new technology "add-on" payments is included in the final Medicare bill